33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Analyze analyst forecasts for the company and compare them with competitors.
919.36M
No peer data available for comparison.
-586.00M
No peer data available for comparison.
0.05
No peer data available for comparison.
31.13M
No peer data available for comparison.
-659.21M
No peer data available for comparison.
1.04B
No peer data available for comparison.
View analysts' price targets and recommendations, and compare them with competitors.
$49.00
Analysts expect the stock price to increase by 45.83%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
9.54B
Better than PATH's revenue of 4.29B.
50.16%
Better than PATH's revenue growth rate of 24.59%.
-4.42B
Worse than PATH's ebitda of -1.05B.
-46.37%
Worse than PATH's ebitda margin of -24.55%.
-5.21B
Worse than PATH's ebit of -1.14B.
-54.67%
Worse than PATH's ebit margin of -26.65%.
791.05M
Worse than PATH's depreciation of 89.84M.
7.90B
Better than PATH's total cash of 4.08B.
82.81%
Worse than PATH's cash as percentage of revenue of 95.16%.
1.73B
Worse than PATH's receivables of 1.65B.
18.17%
Better than PATH's receivables as percentage of revenue of 38.38%.
474.93M
Worse than PATH's inventories of 50.14M.
4.98%
Worse than PATH's inventories as percentage of revenue of 1.17%.
671.79M
Worse than PATH's accounts payable of 49.90M.
7.04%
Worse than PATH's payables as percentage of revenue of 1.16%.
-481.52M
Better than PATH's capital expenditure of -50.16M.
-5.05%
Better than PATH's capex as percentage of revenue of -1.17%.
12.11%
Worse than PATH's weighted average cost of capital (wacc) of 8.81%.
12.14%
Worse than PATH's cost of equity of 8.86%.
4.08%
Equal to PATH's cost of debt of 4.08%.
1.71
Worse than PATH's beta of 1.01.
556.32M
Better than PATH's diluted shares outstanding of 559.93M.
80.28M
Worse than PATH's total debt of 77.82M.
25.31B
Better than PATH's total equity of 6.93B.
25.39B
Better than PATH's total capital of 7.00B.
0.32%
Better than PATH's debt weighting of 1.11%.
99.68%
Better than PATH's equity weighting of 98.89%.
-5.21B
Worse than PATH's ebiat of -1.13B.
-5.42B
Worse than PATH's unlevered free cash flow of -1.41B.
2.00%
Equal to PATH's long-term growth rate of 2.00%.
-54.65B
Worse than PATH's terminal value of -21.13B.
-40.12B
Worse than PATH's enterprise value of -17.49B.
-147.30M
Worse than PATH's net debt of -801.38M.
-39.98B
Worse than PATH's equity value of -16.69B.
-71.86
Worse than PATH's equity value per share of -29.80.
